Coronary Artery Disease

Skip Navigation LinksHome > August 2010 - Volume 21 - Issue 5 > Do drug elution components increase the risk of fracture of...
Coronary Artery Disease:
doi: 10.1097/MCA.0b013e32833aa6a1
Therapy and Prevention

Do drug elution components increase the risk of fracture of sirolimus-eluting stents?

Kawai, Tomokoa; Umeda, Hisashib; Ota, Masayaa; Hattori, Kousukea; Ishikawa, Makotoa; Okumura, Masanoria; Kan, Shinoa; Nakano, Tadashia; Naruse, Hiroyukia; Matsui, Shigerua; Ishii, Junichia; Hishida, Hitoshia; Ozaki, Yukioa

Collapse Box


Objectives: Stent fracture (SF) of sirolimus-eluting stents (SES) has emerged recently in the literature and shown to be associated with an increased risk of restenosis; however, little is known regarding SF after bare-metal stent implantation. We sought to assess whether the use of SES was associated with an increased risk of SF compared with its bare-metal platform, the Bx-velocity stent (BX-BMS).

Methods: A total of 478 lesions in 416 patients undergoing SES implantation and subsequent angiography 6−9 months after the index procedure were compared with 152 lesions in 142 consecutive patients treated with BX-BMS. Stented lesions with total stent-length greater than 40 mm were excluded.

Results: There were no significant differences in overall baseline clinical and anatomic features between the SES and BX-BMS groups, or in SF frequencies at 6–9 month follow-up (4.4% for SES and 1.3% for BX-BMS, P=0.078). In-stent restenosis was observed more often in SF lesions versus non-SF lesions (34.8 vs. 7.7%, P<0.001) in association with a higher 3-year adverse events rate (27.3 vs. 13.6%, P=0.076). The risk of SF at 6–9 months was independently associated with total stent length [odds ratio (OR), 2.13; 95% confidence interval (CI), 1.18–3.83; P=0.012], angulated lesions (OR, 4.25; 95% CI, 1.80–10.00; P=0.001), and right coronary artery lesions (OR, 3.55; 95% CI, 1.46–8.62; P=0.005) but not with SES use.

Conclusion: Stent implantation in right coronary artery lesions, tortuous lesions, and/or longer lesions covered with longer stents, and not SES versus BX-BMS use, may be associated with increased likelihood of SF.

© 2010 Lippincott Williams & Wilkins, Inc.


Article Tools


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.